NCT02428205View on ClinicalTrials.gov

Combined Effects of Early Behavioral Intervention and Propranolol on ASD

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Autism
Interventions
DRUG

Propranolol

Participant will receive Propranolol prior to each EIBI session

DRUG

Placebo

Participant will receive placebo prior to each EIBI session

Trial Locations (1)

65211

Thompson Center for Autism & Neurodevelopmental Disorders, Columbia

All Listed Sponsors
collaborator

Autism Science Foundation

OTHER

lead

University of Missouri-Columbia

OTHER

NCT02428205 - Combined Effects of Early Behavioral Intervention and Propranolol on ASD | Biotech Hunter | Biotech Hunter